A modified transorbital baboon model of reperfused stroke

Stroke

Volumn 31, Issue 12, 2000, Pages 3054-3063

  Huang, Judy ^a   Mocco, J ^a   Choudhri, Tanvir F ^a   Poisik, Alexander ^a   Popilskis, Sulli J ^a   Emerson, Ronald ^a   DelaPaz, Robert L ^a   Khandji, Alexander G ^a   Pinsky, David J ^a   Connolly Jr , E Sander ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Baboons; Cerebral ischemia; Disease models, animal; Reperfusion

Indexed keywords

NITROUS OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR CEREBRAL ARTERY; ARTICLE; BABOON; BRAIN CIRCULATION; BRAIN ISCHEMIA; CONTROLLED STUDY; EVOKED MUSCLE RESPONSE; MALE; MIDDLE CEREBRAL ARTERY; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; REPRODUCIBILITY; STROKE;

EID: 0033667394     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.12.3054     Document Type: Article

References (50)

1. Thresholds in cerebral ischemia: The ischemic penumbra
2. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons
3. Neuronal protection in stroke by an sLe(x)-glycosylated complement inhibitory protein
4. Reperfusion increases neutrophils and leukotriene B4 receptor binding in rat focal ischemia
5. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase
6. Tissue factor contributes to microvascular defects after focal cerebral ischemia
7. Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain
8. E-selectin in focal cerebral ischemia and reperfusion in the rat
9. Exacerbation of cerebral injury in mice which express the P-selectin gent: Identification of P-selectin blockade as a new target for the treatment of stroke
10. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion: Role of neutrophil adhesion in the pathogenesis of stroke
11. Selfotel in acute ischemic stroke: Possible neurotoxic effects of an NMDA antagonist
12. Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat
13. Finding new drugs to treat stroke
14. Double-blind, randomized, placebo-controlled, parallel-group trial of the efficacy and safety of enlimomab (anti-ICAM-1) compared to placebo administered within 6 hours of the onset of symptoms for the treatment of acute ischemic stroke
15. Angiology of the brain of the baboon Pupio ursinus, the vervet monkey Cercopithecus pygerithrus, and the bushbaby Galago senegalensis
16. Xenon inhalation method for measuring cerebral blood flow in conscious baboons
17. Cerebral embolism: Local CBF and edema measured by CT scanning and Xes inhalation
18. Chronic reversible cerebral ischemia: Evaluation of a new baboon model
19. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats
20. Immersion and perfusion staining with 2,3,5-triphenyltetrazolium chloride (TTC) compared to mitochondrial enzymes 6 hours after MCA-occlusion in primates
21. Boehringer Ingelheim drops enlimomab for stroke
22. Transorbital approach to the middle cerebral artery of the squirrel monkey: A technique for experimental cerebral infarction applicable ultrastructural studies
23. Experimental model of stroke in the baboon
24. Experimental acute thrombotic stroke in baboons
25. Variability and reversibility of focal cerebral ischemia in monkeys
26. Experimental regional cerebral ischemia in the middle cerebral artery territory in primates
27. Early reperfusion in the anesthetized baboon reduces brain damage following middle cerebral artery occlusion: A quantitative analysis of infarction volume
28. Xenon and iodine enhanced cerebral CT: A closer look
29. Selective lenticulostriate occlusion in the primate: A highly focal cerebral ischemia model
30. Stable xenon enhanced computed tomography in the study of clinical and pathologic correlates of focal ischemia in baboons
31. Segmental middle cerebral artery occlusion in primates: An method requiring minimal surgery and anesthesia
32. Temporary occlusion of the middle cerebral artery in the monkey: And pathological observations
33. Retrograde transvenous neuroperfusion: A back door treatment for stroke
34. Effect of ascorbic acid on infarct size in experimental focal cerebral ischemia and reperfusion in a primate model
35. Experimental cerebral infarction, II: Clinicopathological model of cerebral infarction
36. Ischemic brain rescue by transvenous perfusion in baboons with venous sinus occlusion
37. Hemorrhagic transformation following tissue plasminogen activator in experimental cerebral infarction
38. Tissue factor localization in non-human primate cerebral tissue
39. Changes in somatosensory evoked potential responses predict outcome in a primate model of focal cerebral ischemia
40. Evaluation of the NMDA-receptor antagonist MK-801 in a primate model of temporary focal cerebral ischemia
41. Post-ischemic treatment with the NMDA-receptor antagonist MK-801 reduces cerebral injury after temporary focal ischemia in a primate model
42. Evaluation of CGS-19755 and barbiturates in a primate model of cerebral ischemia
43. A model of acute focal ischemia in the territory of the anterior cerebral artery in baboons
44. Early components of transcallosal responses in acute ischaemia of the corpus callosum
45. Electrical stimulation of motor cortex in experimental cortical ischaemia: Pyramidal responses at C5 and the surface EMG
46. A model of selective experimental ischaemia in the primate thalamus
47. Changes in somatosensory evoked potentials following an experimental focal ischaemic lesion in thalamus
48. The effects of acute proximal basilar artery occlusion on the primate cerebral circulation
49. Irreversible regional cerebral ischemia: Serial MR imaging and proton MR spectroscopy in a nonhuman primate model
50. The effects of experimental brain-stem ischaemia on brain-stem auditory evoked potentials in primates